What is NDC 47335-108?

47335-108 is the product NDC for Leqselvi (deuruxolitinib phosphate), Deuruxolitinib phosphate 8 mg/1 tablet, film coated, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Leqselvi (Deuruxolitinib phosphate).

Sun Pharmaceutical Industries, Inc., NDC labeler code 47335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Leqselvi?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Leqselvi NDC 47335-108 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)47335-108Labeler and product segments. Claims need a package NDC.

Product NDC at billing width47335-0108Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
47335-108-86	4733501088647335010886	60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (47335-108-86)Marketed from Jun 25, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Leqselvi
Generic name (nonproprietary): deuruxolitinib phosphate
Active ingredients: Deuruxolitinib phosphate — 8 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.NDC labeler code 47335
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 217900
Marketing start: Jun 25, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Bile Salt Export Pump Inhibitors (Mechanism)Breast Cancer Resistance Protein Inhibitors (Mechanism)Janus Kinase Inhibitors (Mechanism)Multidrug and Toxin Extrusion Transporter 2 K Inhibitors (Mechanism)Organic Anion Transporter 3 Inhibitors (Mechanism)
Identifiers: Product ID 47335-108_4f69c6c1-ae0d-4119-9d3a-53986983f840SPL ID 4f69c6c1-ae0d-4119-9d3a-53986983f840
Pharmacologic class: Janus Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N447335010886 followed by a unit qualifier and the quantity

Package 47335-0108-86. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 47335-108

What is NDC 47335-108?: 47335-108 is the product NDC for Leqselvi (deuruxolitinib phosphate), Deuruxolitinib phosphate 8 mg/1 tablet, film coated, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Leqselvi (Deuruxolitinib phosphate).
What is the active ingredient?: Deuruxolitinib phosphate.
Who is the labeler?: Sun Pharmaceutical Industries, Inc., NDC labeler code 47335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Leqselvi?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Leqselvi (Deuruxolitinib phosphate) NDC 47335-108